147 related articles for article (PubMed ID: 10600561)
1. Review: rhinoviruses and their ICAM receptors.
Bella J; Rossmann MG
J Struct Biol; 1999 Dec; 128(1):69-74. PubMed ID: 10600561
[TBL] [Abstract][Full Text] [Related]
2. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand.
Bella J; Kolatkar PR; Marlor CW; Greve JM; Rossmann MG
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4140-5. PubMed ID: 9539703
[TBL] [Abstract][Full Text] [Related]
3. The structure of the two amino-terminal domains of human intercellular adhesion molecule-1 suggests how it functions as a rhinovirus receptor.
Bella J; Kolatkar PR; Marlor CW; Greve JM; Rossmann MG
Virus Res; 1999 Aug; 62(2):107-17. PubMed ID: 10507321
[TBL] [Abstract][Full Text] [Related]
4. Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1.
Staunton DE; Gaur A; Chan PY; Springer TA
J Immunol; 1992 May; 148(10):3271-4. PubMed ID: 1349619
[TBL] [Abstract][Full Text] [Related]
5. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection.
Marlin SD; Staunton DE; Springer TA; Stratowa C; Sommergruber W; Merluzzi VJ
Nature; 1990 Mar; 344(6261):70-2. PubMed ID: 1968231
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of human rhinovirus complexed with ICAM-1 reveals the dynamics of receptor-mediated virus uncoating.
Xing L; Casasnovas JM; Cheng RH
J Virol; 2003 Jun; 77(11):6101-7. PubMed ID: 12743267
[TBL] [Abstract][Full Text] [Related]
7. The crystal structure of coxsackievirus A21 and its interaction with ICAM-1.
Xiao C; Bator-Kelly CM; Rieder E; Chipman PR; Craig A; Kuhn RJ; Wimmer E; Rossmann MG
Structure; 2005 Jul; 13(7):1019-33. PubMed ID: 16004874
[TBL] [Abstract][Full Text] [Related]
8. Mapping a common interaction site used by Plasmodium falciparum Duffy binding-like domains to bind diverse host receptors.
Howell DP; Levin EA; Springer AL; Kraemer SM; Phippard DJ; Schief WR; Smith JD
Mol Microbiol; 2008 Jan; 67(1):78-87. PubMed ID: 18047571
[TBL] [Abstract][Full Text] [Related]
9. Structure of human rhinovirus serotype 2 (HRV2).
Verdaguer N; Blaas D; Fita I
J Mol Biol; 2000 Jul; 300(5):1179-94. PubMed ID: 10903863
[TBL] [Abstract][Full Text] [Related]
10. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor.
Kolatkar PR; Bella J; Olson NH; Bator CM; Baker TS; Rossmann MG
EMBO J; 1999 Nov; 18(22):6249-59. PubMed ID: 10562537
[TBL] [Abstract][Full Text] [Related]
11. Distinct cellular receptor interactions in poliovirus and rhinoviruses.
Xing L; Tjarnlund K; Lindqvist B; Kaplan GG; Feigelstock D; Cheng RH; Casasnovas JM
EMBO J; 2000 Mar; 19(6):1207-16. PubMed ID: 10716921
[TBL] [Abstract][Full Text] [Related]
12. Viral evolution toward change in receptor usage: adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells.
Reischl A; Reithmayer M; Winsauer G; Moser R; Gösler I; Blaas D
J Virol; 2001 Oct; 75(19):9312-9. PubMed ID: 11533194
[TBL] [Abstract][Full Text] [Related]
13. Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule.
Xiao C; Tuthill TJ; Bator Kelly CM; Challinor LJ; Chipman PR; Killington RA; Rowlands DJ; Craig A; Rossmann MG
J Virol; 2004 Sep; 78(18):10034-44. PubMed ID: 15331736
[TBL] [Abstract][Full Text] [Related]
14. A model of the complex between the PfEMP1 malaria protein and the human ICAM-1 receptor.
Bertonati C; Tramontano A
Proteins; 2007 Nov; 69(2):215-22. PubMed ID: 17640071
[TBL] [Abstract][Full Text] [Related]
15. Predictive bioinformatic identification of minor receptor group human rhinoviruses.
Weber C; Pickl-Herk A; Khan AG; Strauss S; Carugo O; Blaas D
FEBS Lett; 2009 Aug; 583(15):2547-51. PubMed ID: 19615999
[TBL] [Abstract][Full Text] [Related]
16. A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1.
Casasnovas JM; Stehle T; Liu JH; Wang JH; Springer TA
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4134-9. PubMed ID: 9539702
[TBL] [Abstract][Full Text] [Related]
17. [Successful prevention of rhinovirus infections with chimeric ICAM-1 immunoglobulin in vitro].
Martin S; Casanovas JM; Staunton DE; Springer TA
Med Klin (Munich); 1993 Apr; 88(4):193-7. PubMed ID: 8098506
[TBL] [Abstract][Full Text] [Related]
18. ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and uncoating.
Hrebík D; Füzik T; Gondová M; Šmerdová L; Adamopoulos A; Šedo O; Zdráhal Z; Plevka P
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33947819
[TBL] [Abstract][Full Text] [Related]
19. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
[TBL] [Abstract][Full Text] [Related]
20. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution.
Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS
J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
